NCT05203276 2023-06-22
Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC
The First People's Hospital of Lianyungang
Phase 2 Unknown
Clinical Trials
7 trialsNCT04613284 2020-11-03
RELIEF
Shanghai Chest Hospital
Phase 4 Unknown
NCT04274270 2020-03-19
SBRTLCES
Peking University Third Hospital
Phase NA Unknown
NCT03706703 2018-10-17
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Unknown
NCT02375022 2015-03-24
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Zhejiang University
Phase 2 Unknown
NCT02350361 2015-01-29
Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.
Peking University Third Hospital
Phase 2/3 Unknown
NCT00657423 2010-09-17
Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)
Xijing Hospital
Phase 3 Unknown